The Interplay Between Self-Determination and Cognitive Bias: Nonlinear Associations Between Myopia Control Knowledge Reserve and Parental Communication Preparedness.

Acral vitiligo, which primarily affects the extremities—especially their distal parts, including the hands, feet, and digits—poses a formidable clinical challenge. Clinically, it is notorious for its recalcitrance to conventional therapies, consistently yielding inferior and delayed repigmentation compared with lesions on the face, neck, or trunk. Moreover, acral lesions on exposed and functionally critical areas profoundly impair quality of life, body image, and social interactions, imposing a substantial disease burden. The resistance to conventional treatments results from multifactorial, encompassing anatomical barriers—impaired drug penetration and limited melanocyte reservoirs—and a local immune milieu characterized by persistent tissue-resident memory T cells. Conventional monotherapies and even optimized phototherapy achieve only negligible repigmentation in acral areas. While JAK inhibitors offer a promising mechanistic breakthrough, their limited efficacy at acral sites indicates that systemic immunomodulation alone is insufficient and must be combined with strategies that directly target local anatomical and immunological barriers. Nevertheless, the integration of mechanistic and therapeutic insights into a cohesive clinical framework for acral vitiligo remains hampered by substantial knowledge gaps. No existing synthesis has systematically translated mechanistic insights into clinical strategies specifically for acral vitiligo. There is a lack of evidence-based guidance for clinicians, given the absence of acral-specific outcome measures, the paucity of comparative trials, and unresolved maintenance therapy questions. Accordingly, this review has three primary objectives: (i) to consolidate current understanding of the anatomical and immunological underpinnings of recalcitrance; (ii) to critically appraise emerging medical, procedural, and surgical interventions, with emphasis on combination strategies; and (iii) to delineate key knowledge gaps—including the lack of standardized endpoints, comparative evidence, and long‑term management data—thereby charting a roadmap for future research and fostering more personalized, biology‑driven management of this therapeutically orphaned subtype. Acral vitiligo represents a significant subtype within the broader spectrum of non-segmental vitiligo. A systematic review focusing on pediatric vitiligo populations indicates that the acral type is the third most common subtype of non-segmental vitiligo, with a prevalence of approximately 17.8%, ranking only behind generalized and localized forms. This epidemiological data underscores its clinical relevance, particularly in younger populations. The condition is not exclusive to children; it can manifest across both pediatric and adult age groups. However, variations in prevalence have been observed across different geographical regions and ethnicities, suggesting potential influences from environmental triggers or genetic predispositions.